These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Koukourakis MI; Giatromanolaki A; Brekken RA; Sivridis E; Gatter KC; Harris AL; Sage EH Cancer Res; 2003 Sep; 63(17):5376-80. PubMed ID: 14500371 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients. Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860 [TBL] [Abstract][Full Text] [Related]
9. The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival. Skjefstad K; Richardsen E; Donnem T; Andersen S; Kiselev Y; Grindstad T; Hald SM; Al-Shibli K; Bremnes RM; Busund LT; Al-Saad S Steroids; 2015 Jun; 98():29-36. PubMed ID: 25668612 [TBL] [Abstract][Full Text] [Related]
10. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation. Botling J; Edlund K; Lohr M; Hellwig B; Holmberg L; Lambe M; Berglund A; Ekman S; Bergqvist M; Pontén F; König A; Fernandes O; Karlsson M; Helenius G; Karlsson C; Rahnenführer J; Hengstler JG; Micke P Clin Cancer Res; 2013 Jan; 19(1):194-204. PubMed ID: 23032747 [TBL] [Abstract][Full Text] [Related]
11. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome. Carus A; Ladekarl M; Hager H; Pilegaard H; Nielsen PS; Donskov F Lung Cancer; 2013 Jul; 81(1):130-7. PubMed ID: 23540719 [TBL] [Abstract][Full Text] [Related]
12. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107 [TBL] [Abstract][Full Text] [Related]
13. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche. Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression. Mattsson JS; Bergman B; Grinberg M; Edlund K; Marincevic M; Jirström K; Pontén F; Hengstler JG; Rahnenführer J; Karlsson MG; Karlsson C; Helenius G; Botling J; Micke P; Gulyas M Cancer Lett; 2015 Jan; 356(2 Pt B):837-45. PubMed ID: 25449785 [TBL] [Abstract][Full Text] [Related]
15. CD99 expression in Merkel cell carcinoma: a case series with an unusual paranuclear dot-like staining pattern. Rajagopalan A; Browning D; Salama S J Cutan Pathol; 2013 Jan; 40(1):19-24. PubMed ID: 23145531 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors. Schmidt M; Hellwig B; Hammad S; Othman A; Lohr M; Chen Z; Boehm D; Gebhard S; Petry I; Lebrecht A; Cadenas C; Marchan R; Stewart JD; Solbach C; Holmberg L; Edlund K; Kultima HG; Rody A; Berglund A; Lambe M; Isaksson A; Botling J; Karn T; Müller V; Gerhold-Ay A; Cotarelo C; Sebastian M; Kronenwett R; Bojar H; Lehr HA; Sahin U; Koelbl H; Gehrmann M; Micke P; Rahnenführer J; Hengstler JG Clin Cancer Res; 2012 May; 18(9):2695-703. PubMed ID: 22351685 [TBL] [Abstract][Full Text] [Related]
19. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients. Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671 [TBL] [Abstract][Full Text] [Related]
20. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Kristiansen G; Schlüns K; Yongwei Y; Denkert C; Dietel M; Petersen I Br J Cancer; 2003 Jan; 88(2):231-6. PubMed ID: 12610508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]